HART / This Pharmaceutical Company Is Growing — Here's How to Invest

Data indicate that inflation is easing. Add to that, the Inflation Reduction Act, which passed last year, allows Medicare to negotiate prices on some more_horizontal

The healthcare sector, the second-largest sector allocation in the S&P 500, performed significantly less poorly than the broader market in 2022 and th more_horizontal

With just two trading days left in 2022, it's safe to say the healthcare sector was significantly less bad than the broader market. As of December 27, more_horizontal

With compelling long-term opportunities available across multiple industry groups, healthcare has the makings of a 2023 redemption, potentially boding more_horizontal

The defensive healthcare sector is living up to its billing this year, as the S&P 500 Health Care Index is lower by just 0.72% compared to 15.37% for more_horizontal

Broadly speaking, the healthcare sector, perhaps owing to its defensive properties, is seen as fairly valued. However, there are plenty of individual more_horizontal

Investors can do good for the world at large while still profiting, and that effort isn't confined to environmental, social, and governance (ESG) stra more_horizontal

The American Heart Association's most recent Presidential Advisory addressed the large gap in research between men's heart health and women's. In a wo more_horizontal